DEXTROAMPHETAMINE SULFATE (Zenzedi) Nursing Considerations

What is the generic name?

DEXTROAMPHETAMINE SULFATE

What is the Trade Name for DEXTROAMPHETAMINE SULFATE?

Zenzedi

What are the Indications for DEXTROAMPHETAMINE SULFATE?

• INDICATIONS AND USAGE Zenzedi ¬Æ (dextroamphetamine sulfate tablets, USP) is indicated for: 1. Narcolepsy. 2. Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted.

References: https://open.fda.gov/